Quintiles Transitional Holdings Inc. (NYSE:Q) – Analysts at William Blair boosted their Q1 2018 earnings estimates for Quintiles Transitional Holdings in a research note issued to investors on Wednesday. William Blair analyst J. Kreger now forecasts that the medical research company will post earnings of $1.19 per share for the quarter, up from their previous estimate of $1.18. William Blair currently has a “Outperform” rating and a $93.42 target price on the stock. William Blair also issued estimates for Quintiles Transitional Holdings’ Q4 2018 earnings at $1.49 EPS and FY2020 earnings at $6.96 EPS.

A number of other equities research analysts have also issued reports on Q. Zacks Investment Research lowered shares of Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a report on Friday, November 3rd. Morgan Stanley increased their target price on shares of Quintiles Transitional Holdings from $96.00 to $121.00 and gave the stock an “overweight” rating in a report on Thursday. BidaskClub lowered shares of Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a report on Friday, August 11th. Jefferies Group LLC restated a “hold” rating and issued a $94.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Finally, Credit Suisse Group restated an “outperform” rating and issued a $125.00 price objective (up from $115.00) on shares of Quintiles Transitional Holdings in a report on Tuesday, October 31st. Eleven analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $103.15.

WARNING: “Analysts Issue Forecasts for Quintiles Transitional Holdings Inc.’s Q1 2018 Earnings (Q)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/analysts-issue-forecasts-for-quintiles-transitional-holdings-inc-s-q1-2018-earnings-q/1695498.html.

Shares of Quintiles Transitional Holdings (NYSE Q) opened at $104.05 on Friday. The stock has a market cap of $21,873.06, a P/E ratio of 23.63, a price-to-earnings-growth ratio of 1.72 and a beta of 0.65. Quintiles Transitional Holdings has a fifty-two week low of $71.90 and a fifty-two week high of $110.67. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.29.

Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. The company had revenue of $2.02 billion for the quarter, compared to analyst estimates of $2.01 billion. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The firm’s quarterly revenue was up 77.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.00 EPS.

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its stake in shares of Quintiles Transitional Holdings by 2.2% in the second quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock valued at $1,144,680,000 after purchasing an additional 280,893 shares during the period. Longview Partners Guernsey LTD lifted its stake in shares of Quintiles Transitional Holdings by 5.8% in the third quarter. Longview Partners Guernsey LTD now owns 9,218,227 shares of the medical research company’s stock valued at $876,377,000 after purchasing an additional 506,780 shares during the period. Glenview Capital Management LLC lifted its stake in shares of Quintiles Transitional Holdings by 29.3% in the second quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after purchasing an additional 2,023,719 shares during the period. Janus Henderson Group PLC lifted its stake in shares of Quintiles Transitional Holdings by 33,092.0% in the second quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after purchasing an additional 6,512,178 shares during the period. Finally, Macquarie Group Ltd. lifted its stake in shares of Quintiles Transitional Holdings by 1.4% in the third quarter. Macquarie Group Ltd. now owns 1,650,268 shares of the medical research company’s stock valued at $156,903,000 after purchasing an additional 23,376 shares during the period. 93.29% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Kevin C. Knightly sold 19,339 shares of Quintiles Transitional Holdings stock in a transaction dated Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the sale, the insider now owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of Quintiles Transitional Holdings stock in a transaction dated Wednesday, September 27th. The shares were sold at an average price of $94.52, for a total transaction of $945,200.00. Following the completion of the sale, the insider now directly owns 27,340 shares in the company, valued at approximately $2,584,176.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 14,175,702 shares of company stock worth $1,361,299,848. Insiders own 6.40% of the company’s stock.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.